{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:45:57Z","timestamp":1771487157701,"version":"3.50.1"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2023-1-4","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T19:58:21Z","timestamp":1680638301000},"page":"1-5","source":"Crossref","is-referenced-by-count":6,"title":["Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report"],"prefix":"10.7573","volume":"12","author":[{"given":"Tanyaporn","family":"Chantarojanasiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2023,4,6]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2023\/04\/dic.2023-1-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T19:58:22Z","timestamp":1680638302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/silymarin-treatment-and-reduction-of-liver-enzyme-levels-in-non-alcoholic-fatty-liver-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2023-1-4","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]}}}